(Q37004632)

17 August 2017

1 reference

title

Evaluating the role of biomarkers for cardiovascular risk prediction: focus on CRP, BNP and urinary microalbumin (English)

1 reference

17 August 2017

0 references

Abigail May

1

1 reference

17 August 2017

Thomas J Wang

series ordinal

2

1 reference

17 August 2017

publication date

1 November 2007

1 reference

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

17 August 2017

published in

1 reference

17 August 2017

volume

7

1 reference

17 August 2017

issue

6

1 reference

17 August 2017

page(s)

793-804

1 reference

C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Major risk factors as antecedents of fatal and nonfatal coronary heart disease events

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Prevalence of conventional risk factors in patients with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Biomarkers of cardiovascular disease: molecular basis and practical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Novel Risk Markers and Clinical Practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Current concepts of the pathogenesis of the acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Inflammatory biomarkers in stable atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

C-reactive protein promotes monocyte chemoattractant protein-1--mediated chemotaxis through upregulating CC chemokine receptor 2 expression in human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

C-Reactive Protein Decreases Prostacyclin Release From Human Aortic Endothelial Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Increased thrombosis after arterial injury in human C-reactive protein-transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Is C-reactive protein an innocent bystander or proatherogenic culprit? The verdict is still out.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Inflammatory markers and the risk of coronary heart disease in men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Race and gender differences in C-reactive protein levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

The value of C-reactive protein in cardiovascular risk prediction: the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Narrative review: Assessment of C-reactive protein in risk prediction for cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Use and misuse of the receiver operating characteristic curve in risk prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Targeting C-reactive protein for the treatment of cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Diabetic nephropathy: diagnosis, prevention, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Microalbuminuria and its relation to cardiovascular disease and risk factors. A population-based study of 1254 hypertensive individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Microalbuminuria. Implications for micro- and macrovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Excessive urinary albumin levels are associated with future cardiovascular mortality in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Microalbuminuria as predictor of increased mortality in elderly people

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Atherosclerotic risk factors are increased in clinically healthy subjects with microalbuminuria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Microalbuminuria in nondiabetic adults: relation of blood pressure, body mass index, plasma cholesterol levels, and smoking: The Gubbio Population Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Brachial artery reactivity in asymptomatic patients with type 2 diabetes mellitus and microalbuminuria (from the Detection of Ischemia in Asymptomatic Diabetics-brachial artery reactivity study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Noninvasive detection of functional alterations of the arterial wall in IDDM patients with and without microalbuminuria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Endothelial function: cardiac events

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Relation of microalbuminuria to adiponectin and augmented C-reactive protein levels in men with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Non-diabetic microalbuminuria, endothelial dysfunction and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Increased atrial and brain natriuretic peptides in adults with cyanotic congenital heart disease: enhanced understanding of the relationship between hypoxia and natriuretic peptide secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Deconvolution analysis of cardiac natriuretic peptides during acute volume overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Plasma natriuretic peptide levels and the risk of cardiovascular events and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide: biomarkers for mortality in a large community-based cohort free of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Plasma brain natriuretic peptide concentration: impact of age and gender

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Impact of obesity on plasma natriuretic peptide levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Effect of body mass index on diagnostic and prognostic usefulness of amino-terminal pro-brain natriuretic peptide in patients with acute dyspnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) multinational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Neither race nor gender influences the usefulness of amino-terminal pro-brain natriuretic peptide testing in dyspneic subjects: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

B-type natriuretic peptide levels in obese patients with advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Multiple biomarkers for the prediction of first major cardiovascular events and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Biomarkers in acute cardiac disease: the present and the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Markers of inflammation and their clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Fluctuating Inflammatory Markers in Patients With Stable Ischemic Heart Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Urinary Albumin and Cardiovascular Profile in the Middle-Aged Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Cardiovascular and metabolic benefits of ACE inhibition: moving beyond blood pressure reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Elevated levels of C-reactive protein before coronary artery bypass grafting predict recurrence of ischemic events

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.7.6.793

21 January 2018

Identifiers

DOI

10.1586/14737159.7.6.793

1 reference

17 August 2017

1 reference